Salivary glutamate and opiorphin as noninvasive markers of irreversible pulpitis in subjects with and without type2 diabetes
Odontology · 2025
DOI: 10.1007/s10266-025-01237-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Odontology, 2025. Verfasst von Aravindha Babu Narayanasamy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Pathology, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research, Chennai, Tamilnadu, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glutamic Acid, Saliva, Salivary Proteins and Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
To assess salivary glutamate and opiorphin levels in subjects with Symptomatic Irreversible Pulpitis (SIP), with and without Type 2 Diabetes (T2D), and to assess their association with pain intensity using the Visual Analogue Scale (VAS). Patients experiencing SIP pain with (n = 25) and without (n = 25) type 2 diabetes along with healthy controls (n = 25) were recruited for this study. VAS scale was used to record the pain.3 mL of unstimulated saliva was collected after thorough oral examination and diagnosis for irreversible pulpitis.The salivary samples were analysed for the pain markers-glutamate and opiorphin by ELISA method. The results were analysed statistically. Diagnostic performance was assessed using ROC curve analysis, and group differences were evaluated by ANOVA. Higher levels of glutamate (7.69 ± 2.07 µg/mL; p < 0.01) and opiorphin (3.96 ± 2.67 ng/mL; p < 0.05) were detected in patients with T2D and SIP, when compared with subjects without T2D. T2D + SIP and nondiabetic SIP groups showed higher opiorphin (d = 1.45, 95% CI [0.83-2.08]; d = 0.99, 95% CI [0.40-1.58]) and glutamate levels (d = 1.31, 95% CI [0.70-1.93]; d = 0.58, 95% CI [0.01-1.15]) versus healthy controls, with T2D + SIP also exceeding ND + SIP for glutamate (d = 1.18, 95% CI [0.58-1.78]). However, the relation between VAS score and levels of glutamate (p < 0.05) and opiorphin (p < 0.001) between diabetic and nondiabetic subjects with dental pain were found to be significantly different. ROC analysis revealed excellent discriminatory performance for glutamate (AUC = 0.843-0.850) across comparisons, whereas opiorphin was limited to distinguishing diabetic from nondiabetic pulpitis (AUC = 0.725). Glutamate levels correlated negatively with pain (VAS; r = -0.351, p = 0.002), while opiorphin correlated positively with pain (r = 0.283, p = 0.014). Salivary glutamate demonstrates strong potential as a diagnostic biomarker for pulpitis in both diabetic and nondiabetic individuals, while opiorphin may serve as an indicator of pain severity rather than disease differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Pathology, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research, Chennai, Tamilnadu, India.
- Department of Biochemistry, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research, Chennai, Tamilnadu, India. mathangibiochem@gmail.com.
Zitieren
APA
Babu Narayanasamy, A., Banu, S. M., Ramya, D., & Mathangi, R. (2025). Salivary glutamate and opiorphin as noninvasive markers of irreversible pulpitis in subjects with and without type2 diabetes. Odontology. https://doi.org/10.1007/s10266-025-01237-8
Vancouver
Babu Narayanasamy A, Banu SM, Ramya D, Mathangi R. Salivary glutamate and opiorphin as noninvasive markers of irreversible pulpitis in subjects with and without type2 diabetes. Odontology. 2025. doi:10.1007/s10266-025-01237-8
BibTeX
@article{BabuNarayanasamy2025,
author = {Babu Narayanasamy, Aravindha and Banu, S Munira and Ramya, D and Mathangi, R},
title = {Salivary glutamate and opiorphin as noninvasive markers of irreversible pulpitis in subjects with and without type2 diabetes},
journal = {Odontology},
year = {2025},
doi = {10.1007/s10266-025-01237-8}
}
EUVIMED